Howard D. Uderman

468 total citations
19 papers, 355 citations indexed

About

Howard D. Uderman is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Howard D. Uderman has authored 19 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 6 papers in Pharmacology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Howard D. Uderman's work include Heart Failure Treatment and Management (4 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Blood Pressure and Hypertension Studies (3 papers). Howard D. Uderman is often cited by papers focused on Heart Failure Treatment and Management (4 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Blood Pressure and Hypertension Studies (3 papers). Howard D. Uderman collaborates with scholars based in United States, Germany and Belgium. Howard D. Uderman's co-authors include Edwin K. Jackson, Robert J. Workman, Neville F. Ford, Maria Rosaria Marino, Georgia Kollia, Frank LaCreta, Dennis M. Grasela, Martin Birkhofer, Daniel E. Salazar and David Puett and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The American Journal of Cardiology and Life Sciences.

In The Last Decade

Howard D. Uderman

19 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Howard D. Uderman United States 12 115 105 75 50 44 19 355
Chandrasekaran Adithan India 14 55 0.5× 188 1.8× 80 1.1× 30 0.6× 154 3.5× 27 597
J. Maddock United Kingdom 15 120 1.0× 29 0.3× 46 0.6× 38 0.8× 71 1.6× 38 530
Nicolas D. Vlachakis United States 14 69 0.6× 182 1.7× 86 1.1× 37 0.7× 10 0.2× 35 494
H. Witzgall Germany 11 48 0.4× 143 1.4× 131 1.7× 55 1.1× 15 0.3× 31 420
K F Ilett Australia 10 52 0.5× 32 0.3× 38 0.5× 12 0.2× 56 1.3× 22 568
Donald D. Smyth Canada 16 65 0.6× 130 1.2× 67 0.9× 55 1.1× 36 0.8× 45 573
Bmy Cheung Hong Kong 9 47 0.4× 152 1.4× 52 0.7× 18 0.4× 14 0.3× 49 461
Dwain Tolbert United States 13 153 1.3× 95 0.9× 135 1.8× 17 0.3× 49 1.1× 36 660
PR Jackson United Kingdom 11 47 0.4× 115 1.1× 117 1.6× 20 0.4× 151 3.4× 21 459
Irving M. Cohen United States 12 46 0.4× 166 1.6× 39 0.5× 12 0.2× 24 0.5× 24 403

Countries citing papers authored by Howard D. Uderman

Since Specialization
Citations

This map shows the geographic impact of Howard D. Uderman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard D. Uderman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard D. Uderman more than expected).

Fields of papers citing papers by Howard D. Uderman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard D. Uderman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard D. Uderman. The network helps show where Howard D. Uderman may publish in the future.

Co-authorship network of co-authors of Howard D. Uderman

This figure shows the co-authorship network connecting the top 25 collaborators of Howard D. Uderman. A scholar is included among the top collaborators of Howard D. Uderman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard D. Uderman. Howard D. Uderman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Damle, Bharat, et al.. (2009). Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite. British Journal of Clinical Pharmacology. 68(5). 682–689. 6 indexed citations
2.
Damle, Bharat, et al.. (2009). Effects of Standard and Supratherapeutic Doses of Nelfinavir on Cardiac Repolarization: A Thorough QT Study. The Journal of Clinical Pharmacology. 49(3). 291–300. 14 indexed citations
3.
Liao, Wei‐Chi, O. Vesterqvist, Carol Delaney, et al.. (2003). Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor, omapatrilat in healthy subjects. British Journal of Clinical Pharmacology. 56(4). 395–406. 18 indexed citations
4.
Salazar, Daniel E., Edyta J. Frackiewicz, Randy Dockens, et al.. (2001). Pharmacokinetics and Tolerability of Buspirone during Oral Administration to Children and Adolescents with Anxiety Disorder and Normal Healthy Adults. The Journal of Clinical Pharmacology. 41(12). 1351–1358. 27 indexed citations
5.
Uderman, Howard D., et al.. (2001). Omapatrilat: Neurohormonal and Pharmacodynamic Profile When Administered with Furosemide. The Journal of Clinical Pharmacology. 41(12). 1291–1300. 1 indexed citations
6.
Grasela, Dennis M., et al.. (2000). Open‐Label, Nonrandomized Study of the Effects of Gatifloxacin on the Pharmacokinetics of Midazolam in Healthy Male Volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(3). 330–335. 12 indexed citations
7.
LaCreta, Frank, et al.. (2000). A Dose‐Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Gatifloxacin in Healthy Adult Men. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(6P2). 49S–58S. 51 indexed citations
8.
Sharma, Amarnath, et al.. (1999). Pharmacokinetics and Pharmacodynamics of Avitriptan during Intravenous Administration in Healthy Subjects. The Journal of Clinical Pharmacology. 39(7). 685–694. 3 indexed citations
9.
Uderman, Howard D., John J. Brennan, Carol L. Delaney, et al.. (1999). Fosinopril and Hydrochlorothiazide Combination versus Individual Components: Lack of a Pharmacokinetic Interaction. Annals of Pharmacotherapy. 33(5). 525–530. 2 indexed citations
10.
Marino, Maria Rosaria, et al.. (1998). Pharmacokinetics and Pharmacodynamics of Irbesartan in Healthy Subjects. The Journal of Clinical Pharmacology. 38(3). 246–255. 60 indexed citations
11.
Marino, Maria Rosaria, et al.. (1997). The Effect of Nefazodone on the Single-Dose Pharmacokinetics of Phenytoin in Healthy Male Subjects. Journal of Clinical Psychopharmacology. 17(1). 27–33. 6 indexed citations
12.
Salazar, Daniel E., et al.. (1995). Pharmacokinetic and Pharmacodynamic Evaluation of Warfarin and Nefazodone Coadministration in Healthy Subjects. The Journal of Clinical Pharmacology. 35(7). 730–738. 24 indexed citations
13.
Marathe, Punit H., et al.. (1995). Pharmacokinetic and Pharmacodynamic Evaluation During Coadministration of Nefazodone and Propranolol in Healthy Men. The Journal of Clinical Pharmacology. 35(11). 1109–1118. 10 indexed citations
14.
Forman, Mervyn B., Howard D. Uderman, Edwin K. Jackson, et al.. (1985). Effects of indomethacin on systemic and coronary hemodynamics in patients with coronary artery disease. American Heart Journal. 110(2). 311–318. 12 indexed citations
15.
Jackson, Edwin K., Howard D. Uderman, William A. Herzer, & Robert A. Branch. (1984). Attenuation of noradrenergic neurotransmission by the thromboxane synthetase inhibitor, UK 38,485. Life Sciences. 35(2). 221–228. 11 indexed citations
16.
Forman, Mervyn B., David Robertson, Michael R. Goldberg, et al.. (1984). Effect of tyramine on myocardial catecholamine release in coronary heart disease. The American Journal of Cardiology. 53(4). 476–480. 10 indexed citations
17.
Uderman, Howard D., Edwin K. Jackson, David Puett, & Robert J. Workman. (1984). Thromboxane Synthetase Inhibitor UK38,485 Lowers Blood Pressure in the Adult Spontaneously Hypertensive Rat. Journal of Cardiovascular Pharmacology. 6(5). 969–972. 22 indexed citations
18.
Nicholson, Wendell E., G. Stephen DeCherney, Richard V. Jackson, et al.. (1983). Plasma Distribution, Disappearance Half-Time, Metabolic Clearance Rate, and Degradation of Synthetic Ovine Corticotropin-Releasing Factor in Man*. The Journal of Clinical Endocrinology & Metabolism. 57(6). 1263–1269. 33 indexed citations
19.
Uderman, Howard D., Robert J. Workman, & Edwin K. Jackson. (1982). Attenuation of the development of hypertension in spontaneously hypertensive rats by the thromboxane synthetase inhibitor, 4′-(imidazol-1-yl) acetophenone. Prostaglandins. 24(2). 237–244. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chandrasekaran Adithan Breakdown of academic impact, for papers by J. Maddock Breakdown of academic impact, for papers by Nicolas D. Vlachakis Breakdown of academic impact, for papers by H. Witzgall Breakdown of academic impact, for papers by K F Ilett Breakdown of academic impact, for papers by Donald D. Smyth Breakdown of academic impact, for papers by Bmy Cheung Breakdown of academic impact, for papers by Dwain Tolbert Breakdown of academic impact, for papers by PR Jackson Breakdown of academic impact, for papers by Irving M. Cohen
Rankless by CCL
2026